RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul Wang to 11-beta-Hydroxysteroid Dehydrogenase Type 1

Back to Details
This is a "connection" page, showing publications Paul Wang has written about 11-beta-Hydroxysteroid Dehydrogenase Type 1.
Paul Wang
Connection Strength
1.238
11-beta-Hydroxysteroid Dehydrogenase Type 1
  1. Chang LL, Wun WA, Wang PS. An inhibitor of 11-? hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells. BMC Pharmacol Toxicol. 2018 07 18; 19(1):45.
    View in: PubMed
    Score: 0.669
  2. Chang LL, Wun WS, Wang PS. Nonylphenol-induced hyperadrenalism can be reversed/alleviated by inhibiting of 11-? hydroxysteroid dehydrogenase type 1. Environ Toxicol Pharmacol. 2016 Jun; 44:1-12.
    View in: PubMed
    Score: 0.570
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support